TitlePHASE II STUDY OF IBERDOMIDE (CC220) MAINTENANCE AFTER AUTOLOGOUS STEM CELL TRANSPLANTION IN NEWLY DIAGNOSED MULTIPLE MYELOMA
Overview / Summary
The study is sponsored by EMN Foundation and focuses on maintenance during first line of therapy.
Patient eligibility criteria
Newly diagnosed multiple myeloma (NDMM) patients in at least partial response (PR) after induction with proteasome inhibitors (PIs) plus IMIDs and single or double ASCT
No publications connected to this trial at the moment